Developing a new localised immunotherapy for advanced prostate cancer

The project in a nutshell

Looking at a new treatment that uses the body's own immune system to destroy prostate cancer cells whilst leaving healthy cells alone.

Why we funded it

Current treatments for advanced prostate cancer come with many side-effects and can stop working quite quickly. A treatment that can help eliminate the cancer by boosting the body's own immune system without any side effects to the patient could be used with hormone therapy or even on its own. It could prove to be an alternative treatment to stop the disease spreading further and one that saves many lives.

Grant information

Institution - King's College London
Researcher - Dr Christine Galustian
Grant award - £49,932
Duration - 2013-2014
Reference - PA12-01 Galustian